Thomas Anderson
CIK: 0001612903
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ZVRA
ZEVRA THERAPEUTICS, INC.
Director
Discretionary Trading P&L
Holdings
About Anderson Thomas
Anderson Thomas (SEC CIK 0001612903) files insider reports with the SEC as Director of ZEVRA THERAPEUTICS, INC. (ZVRA).
Signal8 holds 2 ownership filings by Anderson Thomas, all Form 4s, filed between May 30, 2025 and Jun 18, 2026. Those filings report 2 transactions, from May 29, 2025 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Anderson Thomas's filings is in BOSTON, MA.
Recent filings by Anderson Thomas
Other insiders filing for ZEVRA THERAPEUTICS, INC. (ZVRA)
- McFarlane Neil F., President and CEO
- Thompson Rahsaan, Chief Legal & Compliance
- Watton Corey Michael, Director
- FAVORITO TAMARA A, Director
- Secor Alicia, Director
- Calder Douglas W, Director